
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES137
One RCT250 found that after 12 months, patients treated with irbesartan had significantly lower SBP and DBP levels as compared to those receiving doxazosin, (p<0.05). Level 1+

[@Whelton_2005]

